ArticlePituitary2022
Implementation of functional imaging using
Article in Pituitary, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 23 citations in OpenAlex.
- Functional pituitary adenoma imaging.Reviews in endocrine & metabolic disorders · 2026Review
- Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition).Chinese neurosurgical journal · 2026Review
- Pituitary adenoma imaging as a determinant of acromegaly diagnosis and outcomes.The Journal of clinical endocrinology and metabolism · 2026Review
- The clinical value of [Pituitary · 2026Observational
- The Changing Treatment Paradigm for Prolactinoma-A Prospective Series of 100 Consecutive Neurosurgical Cases.The Journal of clinical endocrinology and metabolism · 2025Article
- Clinical use of [Pituitary · 2024Article
- EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.European journal of nuclear medicine and molecular imaging · 2024Article
- Multidisciplinary Team Care in Pituitary Tumours.Cancers · 2024Review
- Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.Nature reviews. Endocrinology · 2023Review
- Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case.Journal of neurosurgery. Case lessons · 2023Article
- Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?Pituitary · 2023Observational
- The utility of PET for detecting corticotropinomas in Cushing disease: a scoping review.Neurosurgical review · 2023Article
- Recent advances in understanding and managing pituitary adenomas.Faculty reviews · 2023Review
- Multimodal Model for Non-Invasive Detection of DRD2, SSTR2 and ESR1 Receptor Profiling in Pituitary Neuroendocrine Tumors: A Retrospective Study.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report the first experience of our multidisciplinary team with functional imaging using
methodsIn eighteen patients with prolactinoma, referred to our tertiary referral centre because of intolerance or resistance for dopamine agonists (DA), Met-PET/MRI
resultsMet-PET/MRI
conclusionMet-PET/MRI
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.